+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Formulation Market by Dosage Form, Technology, Therapeutic Area, End User - Global Forecast 2025-2030- Product Image
Drug Formulation Market by Dosage Form, Technology, Therapeutic Area, End User - Global Forecast 2025-2030- Product Image
Sale

Drug Formulation Market by Dosage Form, Technology, Therapeutic Area, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967541
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Drug Formulation Market grew from USD 2.42 trillion in 2023 to USD 2.55 trillion in 2024. It is expected to continue growing at a CAGR of 5.70%, reaching USD 3.56 trillion by 2030.

Drug formulation is a crucial component in the pharmaceutical industry, focusing on how active pharmaceutical ingredients (APIs) are combined with excipients to create a final medicinal product. Its necessity lies in ensuring the drug's efficacy, safety, stability, and optimal delivery to the target site. Formulation is applied across various domains, including oral, topical, injectable, and inhalable medications, and serves end-users ranging from patients to healthcare providers and medical institutions. The market for drug formulation is driven by increasing chronic disease prevalence, advancing biotechnology, and growing demand for new therapeutic solutions. Key growth influencers include the rise in personalized medicine, innovative drug delivery systems, and expanding generic and biosimilar markets. Opportunities lie in the development of nano-drug delivery systems, formulation for rare diseases, and leveraging artificial intelligence for more efficient R&D processes. However, the market also faces challenges such as stringent regulatory requirements, high R&D costs, and manufacturing complexities. There are significant intellectual property concerns, making it difficult for new entrants to gain a foothold without substantial investment and innovation. Best areas for innovation include biologics formulation, solubility enhancement techniques for poorly soluble drugs, and sustainable manufacturing processes. The market remains highly competitive with major players investing heavily in research and partnerships to maintain their competitive edge. Partnerships between tech companies and pharmaceutical firms are particularly promising, offering advances in data analytics and process automation. For business growth, recommendations include focusing on flexible formulation platforms that can cater to diverse therapeutic needs, and investing in continuous manufacturing technologies for efficiency gains. Enhanced collaboration across the industry and regulatory bodies can facilitate smoother innovation pathways. Overall, the drug formulation market is dynamic, with significant opportunities available for those able to navigate its complexities and leverage new technological advancements.

Understanding Market Dynamics in the Drug Formulation Market

The Drug Formulation Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Prevalence of chronic diseases and need for effective treatments
    • Government initiatives encouraging drug development and discovery
    • Rise of personalized and tailored medicine and therapies
  • Market Restraints
    • Adverse recalls of drugs and medications
  • Market Opportunities
    • Advancements in drug delivery and dosage technologies
    • Investments in CDMOs to develop generic drugs
  • Market Challenges
    • Complex development and processing of drug formulations

Exploring Porter’s Five Forces for the Drug Formulation Market

Porter’s Five Forces framework further strengthens the insights of the Drug Formulation Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Drug Formulation Market

External macro-environmental factors deeply influence the performance of the Drug Formulation Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Drug Formulation Market

The Drug Formulation Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Drug Formulation Market

The Drug Formulation Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Drug Formulation Market

The Drug Formulation Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Formulation Market, highlighting leading vendors and their innovative profiles. These include 3M Company, AbbVie Inc., Amgen, Inc., AstraZeneca plc., Bayer AG, Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Catalent, Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, Gerresheimer AG, Gilead Sciences, Inc., GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Halozyme Therapeutics, Inc., Johnson & Johnson Services, Inc., Marksans Pharma Ltd., Medicef Pharma, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi SA, Teva Pharmaceuticals Industries Ltd., and The Bristol-Myers Squibb Company.

Market Segmentation & Coverage

This research report categorizes the Drug Formulation Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Dosage Form
    • Inhalation Formulations
      • Dry Powder Inhaler
      • Nebulizer
      • Pressurized Metered Dose Inhaler
    • Oral Formulations
      • Capsules
      • Gummies
      • Lozenges & Pastilles
      • Powders & Granules
      • Tablets
    • Parenteral Formulations
      • Emulsions
      • Gels
      • Powders
      • Solutions
      • Suspensions
    • Topical Formulations
      • Creams, Lotions, & Foams
      • Gels, Tinctures, & Powders
      • Ointments & Oils
      • Pastes
      • Sprays & Patches
  • Technology
    • Immediate-Release Formulations
    • Liposomal Formulations
    • Microsphere Formulations
    • Modified-Release Formulations
    • Nanoformulations
    • Self-Emulsifying Drug Delivery Systems
    • Solid Dispersion Formulations
  • Therapeutic Area
    • Cardiovascular
    • Central Nervous System
    • Dermatology
    • Endocrinology
    • Gastrointestinal
    • Immunology
    • Infectious Diseases
    • Oncology
    • Ophthalmology
    • Pain Management
    • Respiratory
  • End User
    • Academic & Research Institutions
    • Contract Development & Manufacturing Organizations
    • Hospitals & Clinics
    • Pharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of chronic diseases and need for effective treatments
5.1.1.2. Government initiatives encouraging drug development and discovery
5.1.1.3. Rise of personalized and tailored medicine and therapies
5.1.2. Restraints
5.1.2.1. Adverse recalls of drugs and medications
5.1.3. Opportunities
5.1.3.1. Advancements in drug delivery and dosage technologies
5.1.3.2. Investments in CDMOs to develop generic drugs
5.1.4. Challenges
5.1.4.1. Complex development and processing of drug formulations
5.2. Market Segmentation Analysis
5.2.1. Dosage Form: Convenience and effectiveness of oral formulations for chronic treatments
5.2.2. End User: Rising investments in drug developments by pharmaceutical companies
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Drug Formulation Market, by Dosage Form
6.1. Introduction
6.2. Inhalation Formulations
6.2.1. Dry Powder Inhaler
6.2.2. Nebulizer
6.2.3. Pressurized Metered Dose Inhaler
6.3. Oral Formulations
6.3.1. Capsules
6.3.2. Gummies
6.3.3. Lozenges & Pastilles
6.3.4. Powders & Granules
6.3.5. Tablets
6.4. Parenteral Formulations
6.4.1. Emulsions
6.4.2. Gels
6.4.3. Powders
6.4.4. Solutions
6.4.5. Suspensions
6.5. Topical Formulations
6.5.1. Creams, Lotions, & Foams
6.5.2. Gels, Tinctures, & Powders
6.5.3. Ointments & Oils
6.5.4. Pastes
6.5.5. Sprays & Patches
7. Drug Formulation Market, by Technology
7.1. Introduction
7.2. Immediate-Release Formulations
7.3. Liposomal Formulations
7.4. Microsphere Formulations
7.5. Modified-Release Formulations
7.6. Nanoformulations
7.7. Self-Emulsifying Drug Delivery Systems
7.8. Solid Dispersion Formulations
8. Drug Formulation Market, by Therapeutic Area
8.1. Introduction
8.2. Cardiovascular
8.3. Central Nervous System
8.4. Dermatology
8.5. Endocrinology
8.6. Gastrointestinal
8.7. Immunology
8.8. Infectious Diseases
8.9. Oncology
8.10. Ophthalmology
8.11. Pain Management
8.12. Respiratory
9. Drug Formulation Market, by End User
9.1. Introduction
9.2. Academic & Research Institutions
9.3. Contract Development & Manufacturing Organizations
9.4. Hospitals & Clinics
9.5. Pharmaceutical Companies
10. Americas Drug Formulation Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Drug Formulation Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Drug Formulation Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Glenmark Launches Triple Drug Formulation for Type 2 Diabetes Patients in India
13.3.2. Neurocrine Biosciences Announces U.S. FDA Accepts New Drug Application for INGREZZA (valbenazine) Oral Granules Sprinkle Formulation
13.3.3. Merck & XtalPi Collaboration Optimizes Drug Formulations with AI-Powered Techniques
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. DRUG FORMULATION MARKET RESEARCH PROCESS
FIGURE 2. DRUG FORMULATION MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DRUG FORMULATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DRUG FORMULATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG FORMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
FIGURE 7. GLOBAL DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 11. GLOBAL DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL DRUG FORMULATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL DRUG FORMULATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS DRUG FORMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS DRUG FORMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES DRUG FORMULATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES DRUG FORMULATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG FORMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRUG FORMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. DRUG FORMULATION MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. DRUG FORMULATION MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DRUG FORMULATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DRUG FORMULATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRUG FORMULATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG FORMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. DRUG FORMULATION MARKET DYNAMICS
TABLE 7. GLOBAL DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG FORMULATION MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DRUG FORMULATION MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG FORMULATION MARKET SIZE, BY PRESSURIZED METERED DOSE INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DRUG FORMULATION MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG FORMULATION MARKET SIZE, BY GUMMIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DRUG FORMULATION MARKET SIZE, BY LOZENGES & PASTILLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG FORMULATION MARKET SIZE, BY POWDERS & GRANULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DRUG FORMULATION MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG FORMULATION MARKET SIZE, BY EMULSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DRUG FORMULATION MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG FORMULATION MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DRUG FORMULATION MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG FORMULATION MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DRUG FORMULATION MARKET SIZE, BY CREAMS, LOTIONS, & FOAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG FORMULATION MARKET SIZE, BY GELS, TINCTURES, & POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DRUG FORMULATION MARKET SIZE, BY OINTMENTS & OILS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG FORMULATION MARKET SIZE, BY PASTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DRUG FORMULATION MARKET SIZE, BY SPRAYS & PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG FORMULATION MARKET SIZE, BY IMMEDIATE-RELEASE FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DRUG FORMULATION MARKET SIZE, BY LIPOSOMAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG FORMULATION MARKET SIZE, BY MICROSPHERE FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DRUG FORMULATION MARKET SIZE, BY MODIFIED-RELEASE FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG FORMULATION MARKET SIZE, BY NANOFORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DRUG FORMULATION MARKET SIZE, BY SELF-EMULSIFYING DRUG DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG FORMULATION MARKET SIZE, BY SOLID DISPERSION FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG FORMULATION MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DRUG FORMULATION MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG FORMULATION MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DRUG FORMULATION MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DRUG FORMULATION MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DRUG FORMULATION MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DRUG FORMULATION MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DRUG FORMULATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DRUG FORMULATION MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DRUG FORMULATION MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DRUG FORMULATION MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DRUG FORMULATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DRUG FORMULATION MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DRUG FORMULATION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DRUG FORMULATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS DRUG FORMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. CANADA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 85. CANADA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 86. CANADA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 87. CANADA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 88. CANADA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 89. CANADA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. CANADA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 91. CANADA DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. MEXICO DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 93. MEXICO DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 94. MEXICO DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 95. MEXICO DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 96. MEXICO DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 97. MEXICO DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. MEXICO DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 99. MEXICO DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES DRUG FORMULATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 116. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC DRUG FORMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 123. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 125. AUSTRALIA DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. CHINA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 127. CHINA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 128. CHINA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 129. CHINA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 130. CHINA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 131. CHINA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 132. CHINA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 133. CHINA DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. INDIA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 135. INDIA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 136. INDIA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 137. INDIA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 138. INDIA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 139. INDIA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. INDIA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 141. INDIA DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. INDONESIA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 143. INDONESIA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 144. INDONESIA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 145. INDONESIA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 146. INDONESIA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 148. INDONESIA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 149. INDONESIA DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. JAPAN DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 151. JAPAN DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 152. JAPAN DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 153. JAPAN DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 154. JAPAN DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 155. JAPAN DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 156. JAPAN DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 157. JAPAN DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. MALAYSIA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 159. MALAYSIA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 160. MALAYSIA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 161. MALAYSIA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 162. MALAYSIA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 163. MALAYSIA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. MALAYSIA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 165. MALAYSIA DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. PHILIPPINES DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 167. PHILIPPINES DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 168. PHILIPPINES DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 169. PHILIPPINES DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 170. PHILIPPINES DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 171. PHILIPPINES DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 172. PHILIPPINES DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 173. PHILIPPINES DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. SINGAPORE DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 175. SINGAPORE DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 176. SINGAPORE DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 177. SINGAPORE DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 178. SINGAPORE DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 179. SINGAPORE DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 180. SINGAPORE DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 181. SINGAPORE DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. SOUTH KOREA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 183. SOUTH KOREA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 184. SOUTH KOREA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 185. SOUTH KOREA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 186. SOUTH KOREA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 187. SOUTH KOREA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. SOUTH KOREA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 189. SOUTH KOREA DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. TAIWAN DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 191. TAIWAN DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 192. TAIWAN DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 193. TAIWAN DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 194. TAIWAN DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 195. TAIWAN DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. TAIWAN DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 197. TAIWAN DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. THAILAND DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 199. THAILAND DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 200. THAILAND DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 201. THAILAND DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 202. THAILAND DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 203. THAILAND DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 204. THAILAND DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 205. THAILAND DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. VIETNAM DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 207. VIETNAM DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 208. VIETNAM DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 209. VIETNAM DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 210. VIETNAM DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 211. VIETNAM DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 212. VIETNAM DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 213. VIETNAM DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA DRUG FORMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 223. DENMARK DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 224. DENMARK DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 225. DENMARK DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 226. DENMARK DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 227. DENMARK DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 228. DENMARK DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 229. DENMARK DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 230. DENMARK DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. EGYPT DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 232. EGYPT DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 233. EGYPT DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 234. EGYPT DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 235. EGYPT DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 236. EGYPT DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. EGYPT DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 238. EGYPT DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. FINLAND DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 240. FINLAND DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 241. FINLAND DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 242. FINLAND DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 243. FINLAND DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 244. FINLAND DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 245. FINLAND DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 246. FINLAND DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. FRANCE DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 248. FRANCE DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 249. FRANCE DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 250. FRANCE DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 251. FRANCE DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 252. FRANCE DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 253. FRANCE DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 254. FRANCE DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. GERMANY DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 256. GERMANY DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 257. GERMANY DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 258. GERMANY DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 259. GERMANY DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 260. GERMANY DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 261. GERMANY DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 262. GERMANY DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. ITALY DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 272. ITALY DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 273. ITALY DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 274. ITALY DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 275. ITALY DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 276. ITALY DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 277. ITALY DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 278. ITALY DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. NETHERLANDS DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 280. NETHERLANDS DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 281. NETHERLANDS DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. NIGERIA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 288. NIGERIA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 289. NIGERIA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 290. NIGERIA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 291. NIGERIA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 292. NIGERIA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 293. NIGERIA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 294. NIGERIA DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. NORWAY DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 296. NORWAY DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 297. NORWAY DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 298. NORWAY DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 299. NORWAY DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 300. NORWAY DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 301. NORWAY DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 302. NORWAY DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. POLAND DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 304. POLAND DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 305. POLAND DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 306. POLAND DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 307. POLAND DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 308. POLAND DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 309. POLAND DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 310. POLAND DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. QATAR DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 312. QATAR DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 313. QATAR DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 314. QATAR DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 315. QATAR DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 316. QATAR DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 317. QATAR DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 318. QATAR DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. RUSSIA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 320. RUSSIA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 321. RUSSIA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 322. RUSSIA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 323. RUSSIA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 324. RUSSIA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 325. RUSSIA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 326. RUSSIA DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 328. SAUDI ARABIA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 329. SAUDI ARABIA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 330. SAUDI ARABIA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 331. SAUDI ARABIA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 332. SAUDI ARABIA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 333. SAUDI ARABIA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 334. SAUDI ARABIA DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 335. SOUTH AFRICA DRUG FORMULATION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 336. SOUTH AFRICA DRUG FORMULATION MARKET SIZE, BY INHALATION FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 337. SOUTH AFRICA DRUG FORMULATION MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 338. SOUTH AFRICA DRUG FORMULATION MARKET SIZE, BY PARENTERAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 339. SOUTH AFRICA DRUG FORMULATION MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 340. SOUTH AFRICA DRUG FORMULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 341. SOUTH AFRICA DRUG FORMULATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 342. SOUTH AFRICA DRUG FORMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 343. SPAIN DRU

Companies Mentioned

The leading players in the Drug Formulation market, which are profiled in this report, include:
  • 3M Company
  • AbbVie Inc.
  • Amgen, Inc.
  • AstraZeneca plc.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Boston Scientific Corporation
  • Catalent, Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Gerresheimer AG
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals Limited
  • Halozyme Therapeutics, Inc.
  • Johnson & Johnson Services, Inc.
  • Marksans Pharma Ltd.
  • Medicef Pharma
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Teva Pharmaceuticals Industries Ltd.
  • The Bristol-Myers Squibb Company

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages189
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 2.55 Trillion
Forecasted Market Value ( USD ) by 2030 $ 3.56 Trillion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Drug Formulation Global Market Report 2024 - Product Image

Drug Formulation Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Bioavailability Enhancement Technologies & Services Market by Offering, Drug Formulation, Application, End-User - Global Forecast 2025-2030 - Product Image

Bioavailability Enhancement Technologies & Services Market by Offering, Drug Formulation, Application, End-User - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Capecitabine Market by Drug Formulation, Distribution Channel, End Users, Drug Type - Global Forecast 2025-2030 - Product Image

Capecitabine Market by Drug Formulation, Distribution Channel, End Users, Drug Type - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Doxorubicin Market Size, Share & Trends Analysis Report By Drug Formulation (Lyophilized Powder, Doxorubicin Injection), By Application, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Doxorubicin Market Size, Share & Trends Analysis Report By Drug Formulation (Lyophilized Powder, Doxorubicin Injection), By Application, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 80 Pages
  • Global
From
A Journal of Drug Formulation, Development and Production - Product Image

A Journal of Drug Formulation, Development and Production

  • Journal Icon Journal
  • 60 Pages
  • Global
From

About the Drug Formulation Market

The Drug Formulation market is a key component of the Drug Discovery process. It involves the development of a drug product that is suitable for administration to a patient. This includes the selection of the appropriate drug delivery system, the optimization of the drug's physical and chemical properties, and the development of a manufacturing process. The formulation of a drug is a complex process that requires expertise in a variety of disciplines, including chemistry, pharmacology, and engineering. The Drug Formulation market is highly competitive, with a number of companies offering a range of services. These include formulation development, analytical testing, and manufacturing. Companies in the market include Pfizer, Merck, Novartis, and GlaxoSmithKline. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.